Sawada M

No ORCID on file · 32 papers in corpus
2017
Clinical case reports ·doi:10.1002/ccr3.766

The incidence of cesarean section (c-section) has increased worldwide. Because the major risk factor for uterine scar dehiscence (USD) is a previous c-section, the rate of this complication has also increased. Its clinical significance and …

other 2014
Case Reports in Obstetrics and Gynecology ·doi:10.1155/2014/648485

Endometriosis is defined as the presence of endometrium-like tissues at extrauterine sites, most commonly in the abdominal cavity. Lymph node endometriosis is a rare but clinically important type of endometriosis that can mimic lymph node m…

article 2014
Case Reports in Obstetrics and Gynecology ·doi:10.1155/2014/569295

Malignant changes in endometriosis are often reported, but those in adenomyosis are rare. We report a case of endometrioid adenocarcinoma arising from adenomyosis. Case Presentation. A 57-year-old woman presenting with vaginal bleeding was …

other 1987
Nihon Sanka Fujinka Gakkai zasshi ·doi:10.1007/978-1-4613-1717-3_58

To overcome the dose limiting toxicity of cisplatin we administered high-dose (12 mg/kg) cisplatin together with hypertonic (3%) saline to tumor-bearing nude mice three times at four day intervals. The heterotransplanted human ovarian tumor…

other 1987
Nihon Sanka Fujinka Gakkai zasshi

Experimental chemotherapy was performed using the human tumor-nude mouse system. The tumors were mucinous cystadenocarcinoma (OVA-1), undifferentiated carcinoma (OVA-2), endometrioid adenocarcinoma (OVA-3), serous cystadenocarcinoma (OVA-4)…

other 1983
Nihon Sanka Fujinka Gakkai zasshi

Immunosuppressive acidic protein(IAP) levels were measured in human sera by a single radial immunodiffusion using an IAP plate. Sera were obtained from healthy controls (79 females), patients with myoma uteri (53 cases), patients with benig…

other 1982
Nihon Sanka Fujinka Gakkai zasshi

The effects of human interferon on the growth of xenografted human tumors were studied. Human lymphoblastoid interferon (IFN) was administered intraperitoneally to nude mice with yolk sac tumors of the ovary (YST-1 and YST-2) and endometria…